Latanoprost ophthalmic solution 0.005% with 0.02% BAK or travoprost 0.004% ophthalmic solution with sofZia were tested against the following bacteria and fungi: Staphylococcus aureus (ATCC 6538 ...

Gland Pharma, a generic injectable–focused pharmaceutical company, has received approval from the United States Food and Drug Administration (FDA) for latanoprost ophthalmic solution, 0.005% (2.5 mL ...

Background: Although in vitro and in vivo laboratory studies have suggested that benzalkonium chloride (BAK) in topical ophthalmic solutions ... preservative systems: latanoprost 0.005% with ...